Prévisions

Aucune donnée d'analyste n'est disponible pour cette entreprise.

Actualités Accéder au fil d'actualités

Samsung Biologics to acquire Human Genome Sciences from GSK for $280 million

Samsung Biologics is expanding its U.S. presence by acquiring Human Genome Sciences from GSK for $280 million. The Rockville, Maryland site includes two production facilities with a combined capacity of 60,000 liters and is the company’s first manufacturing location in the United States. Samsung Biologics plans additional investments to expand capacity and upgrade technology; the deal is expected to close at the end of the first quarter. » Plus sur finanzen.net